Press Releases
Mar. 24, 2026
Weaning, more than a change of food: it shapes a life-long, healthy gut
Indeterminate
Baylor College of Medicine - Texas
Owner: Baylor College of Medicine
Mar. 24, 2026
5.4 Million Texans Have No Health Insurance — ChatWithDr.com Offers Them a $39.99 Online Doctor Visit
Neutral
EIN Presswire
Mar. 23, 2026
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Indeterminate
GlobeNewswire, Inc.
Mar. 24, 2026
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire, Inc.
Mar. 23, 2026
Children’s National launches Division of AI Research to lead the future of artificial intelligence in pediatric medicine
Indeterminate
GlobeNewswire, Inc.
Mar. 24, 2026
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Full-Year 2025 Results and Highlights Key Regulatory and Commercial Progress
Indeterminate
GlobeNewswire, Inc.
Mar. 24, 2026
TechArena Launches Advisory Practice Led by Former AWS, Intel, & Microsoft C-Suite Executives
Indeterminate
GlobeNewswire, Inc.
Mar. 23, 2026
NewAmsterdam Pharma Announces Three Presentations at the 2026 American College of Cardiology Annual Scientific Session
Indeterminate
GlobeNewswire, Inc.
Apr. 2, 2026
NCLA Wins Deletion of Data from Covid Spyware Massachusetts Auto-Installed on > 1 Million Phones
Indeterminate
GlobeNewswire, Inc.
Mar. 19, 2026
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Operating and Financial Results
Indeterminate
GlobeNewswire, Inc.
Mar. 19, 2026
Zion Health Introduces Charcoal Face Mask – Deep Pore Cleanser for Clearer, Refined Skin
Neutral
EIN Presswire
Mar. 10, 2026
D’Art Delivers Experiential Wellness Center Design for Maharishi Ayurveda
Neutral
EIN Presswire
Mar. 18, 2026
60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract
Indeterminate
GlobeNewswire, Inc.
Mar. 18, 2026
Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors
Indeterminate
GlobeNewswire, Inc.
Mar. 19, 2026
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer
Indeterminate
GlobeNewswire, Inc.